Parallax Volatility Advisers, L.P. Aeterna Zentaris Inc. Transaction History

Parallax Volatility Advisers, L.P.

  • $53.5 Billion
  • Q3 2024

A detailed history of Parallax Volatility Advisers, L.P. transactions in Aeterna Zentaris Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 125,000 shares of AEZS stock, worth $500,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
125,000
Holding current value
$500,000
% of portfolio
0.0%

Shares

0 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
No transaction found.

About Aeterna Zentaris Inc.

AEZS Quotes by TradingView
  • Ticker AEZS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,855,880
  • Market Cap $19.4M
  • Description
  • Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...
More about AEZS
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email